Physician profile
Dane Hassani
NPI 1003901430
$9,364.14
in general payments reported to CMS, 2019-2025
10 companies · $2,085 in 2025
The $2,085 reported for 2025 was more than what 97% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,534 · 2020: $1,373 · 2021: $491 · 2022: $580 · 2023: $300 · 2024: $1,002 · 2025: $2,085.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,371 · Food and Beverage: $15.51.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,371.00 |
| Food and Beverage | $15.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $3,773.32 | 2019-2020 | |
| Ge Healthcare | $2,294.00 | 2024-2025 | |
| Edwards Lifesciences Corporation | $1,580.00 | 2019-2023 | |
| Medtronic, INC. | $777.00 | 2024 | |
| Covidien LP | $350.00 | 2019 | |
| Merck Sharp & Dohme LLC | $269.54 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $114.02 | 2019 | |
| Qol Medical, LLC | $99.27 | 2021 | |
| Acacia Pharma INC | $91.48 | 2021 | |
| Boston Scientific Corporation | $15.51 | 2024 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dane Hassani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.